Mindray Bio-Medical's controlling shareholder pledges, releases shares

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced that its controlling shareholder, Magnifice (HK) Limited, has pledged 5,800,000 shares of the company. This represents 1.95% of Magnifice (HK)'s total holdings and 0.48% of the company's total share capital. The pledge began on October 20, 2025, and is set to expire upon completion of registration for its release. The shares were pledged to Shanghai Pudong Development Bank, Shenzhen Branch, for other purposes.

In a separate transaction, Magnifice (HK) Limited also released a pledge on 4,850,000 shares, representing 1.63% of its holdings and 0.40% of the company's total share capital. This release pertained to a pledge initiated on November 5, 2024, which concluded on October 20, 2025, with Shanghai Pudong Development Bank, Shenzhen Branch as the pledgee.

As of the announcement date, Magnifice (HK) Limited holds 296,951,000 shares, with 36,100,000 shares currently pledged, accounting for 12.16% of its holdings and 2.98% of the company's total share capital. The company affirmed that the pledged shares are not subject to freezing, auction, or trust arrangements, and there is no immediate risk of a forced sale.